Pitt research identifies new target in brain for treating schizophrenia

November 06, 2008

Study published in Proceedings of National Academy of Sciences shows that orbitofrontal cortex responds to current and experimental antipsychotic drugs

PITTSBURGH--Research from the University of Pittsburgh could expand the options for controlling schizophrenia by identifying a brain region that responds to more than one type of antipsychotic drug. The findings illustrate for the first time that the orbitofrontal cortex could be a promising target for developing future antipsychotic drugs-even those that have very different mechanisms of action. The study will be published during the week of Nov. 3 in the online edition of the journal Proceedings of National Academy of Sciences, with a print version to follow.

Bita Moghaddam, a professor in the Department of Neuroscience in Pitt's School of Arts and Sciences and the paper's lead author, found that schizophrenia-like activity in the orbitofrontal cortex-a brain region responsible for cognitive activity such as decision making-could be triggered by the two different neurotransmitters linked to schizophrenia: dopamine and glutamate. Brain activity was then normalized both by established antipsychotic medications that regulate only dopamine and by experimental treatments that specifically target glutamate.

"The orbitofrontal cortex is an area that's been somewhat neglected in schizophrenia research. This study should encourage researchers to focus on this brain region in imaging and other human studies, and also to use as a model for developing antipsychotic drugs," Moghaddam said. "Schizophrenia appears to be caused by very diverse and sometimes rare genetic mutations. Diverse mutations can end up causing the same disease if they disrupt the function of a common group of neurons or networks of neurons. We think that the key to understanding the pathophysiology of schizophrenia and finding better treatments is to identify these networks. This data suggests that the orbitofrontal cortex may be a critical component in networks affected by schizophrenia."

Working with UPMC neurology resident Houman Homayoun, Moghaddam first established that dopamine and glutamate could, separately, produce schizophrenia-like symptoms in the orbitofrontal cortex. They first simulated symptoms brought on by irregular neural receptors of glutamate. Studies within the last few years-including work by Moghaddam at Yale University-have shown that under-functioning glutamate receptors known as NMDA receptors can produce schizophrenia-like symptoms. Moghaddam and Homayoun found that stunting the NMDA receptors resulted in schizophrenia-like effects in the orbitofrontal cortex. The team also used a dose of amphetamine to simulate dopamine-related schizophrenia symptoms in the orbitofrontal cortex; schizophrenia is often linked to an excess of dopamine in the brain.

Moghaddam and Homayoun then tested the currently prescribed medication-a treatment developed more than 50 years ago that targets neural receptors of dopamine-and new experimental drugs that work on the glutamate system. They found that both medications normalized brain activity.

University of Pittsburgh

---

---

	Surviving Schizophrenia: A Manual for Families, Patients, and Providers by E. Fuller Torrey (Author) Since its first publication in 1983, Surviving Schizophrenia has become the standard reference book on the disease and has helped thousands of patients, their families and mental health professionals. In clear language, this much–praised and important book describes the nature, causes, symptoms, treatment and course of schizophrenia and also explores living with it from both the patient and the family's point of view. This new, completely updated fifth edition includes the latest research findings on what causes the disease as well as information about the newest drugs for treatment and answers to the questions most often asked by families, consumers and providers.
	Surviving Schizophrenia: A Memoir by Twynham Press What you are about to read is a true story. I am an apparently normal happily married middle class mother of four, living the humdrum existence of an ordinary housewife. And I have a diagnosis of schizophrenia, something that I have always felt a deep sense of shame and embarrassment about, and kept hidden for many years. I have agonised for many years over whether to make my story public – I have written this book, re-written it, changed the names, changed them back again, written it again under a pseudonym, tried to change it into a novel... Finally, last year on a writing holiday at the wonderful Arvon Centre in Totleigh Barton, Devon, matters became clear. This is my story, and I am ready to stand by it. It is a true story and any value that it has for others lies in...
	Me, Myself, and Them: A Firsthand Account of One Young Person's Experience with Schizophrenia (Adolescent Mental Health Initiative) by Kurt Snyder (Author), Raquel E. Gur M.D. (Author), Linda Wasmer Andrews (Author) During his second semester at college, Kurt Snyder became convinced that he was about to discover a fabulously important mathematical principle, spending hours lost in daydreams about numbers and symbols. In time, his thoughts took a darker turn, and he became preoccupied with the idea that cars were following him, or that strangers wanted to harm him. Kurt's mind had been hijacked by schizophrenia, a severe mental disorder that typically strikes during the late teen or young adult years. In Me, Myself, and Them, Kurt, now an adult, looks back from the vantage point of recovery and eloquently describes the debilitating changes in thoughts and perceptions that took hold of his life during his teens and twenties. As a memoir, this book is remarkable for its unvarnished look at the slow...
	The Complete Family Guide to Schizophrenia: Helping Your Loved One Get the Most Out of Life by Kim T. Mueser PhD (Author), Susan Gingerich MSW (Author) Will the person you love ever get better? Chances are you've grappled with the question. With care and support from their families, people with schizophrenia can and do make vast improvements. Noted therapists Kim Mueser and Susan Gingerich deepen your understanding of the illness and cover a wide range of effective treatments. Based on decades of research and experience, they offer pragmatic suggestions for dealing with depression, psychosis, and other symptoms. They show you how to prioritize needs, resolve everyday problems, and encourage your loved one to set life goals. Plus, individual sections highlight special issues for parents, children, siblings, and partners. Whether you’re facing schizophrenia for the first time or you’ve dealt with its impact for years, you’ll discover...
	Recovered, Not Cured: A Journey Through Schizophrenia by Richard McLean (Author) This very personal exploration of schizophrenia explores each stage, from the early signs and reactions from friends and family to seeking help and the challenges of recovery. McLean bravely shares his paranoid delusions and offers both a verbal and a visual experience by including digital artwork he created to help objectify and control his impulses and fears. As McLean relates his experiences step by step, issues of sexuality, identity, and drug abuse are discussed, along with the overarching issues relating to mental health and the medical profession. Messages from online posters who either have suffered from mental illness or have cared for the mentally ill are included throughout, adding more perspectives to the author's personal experiences. This powerful combination of words and...
	Schizophrenia: Causes, Symptoms, Signs, Diagnosis and Treatments - Revised Edition - Illustrated by S. Smith by National Institute of Mental Health (Author), National Institutes of Health (Author), US Department of Health and Human Services (Author), S. Smith (Illustrator) This Schizophrenia Book is the revised version of the popular original version titled "Schizophrenia Causes, Symptoms, Signs, Diagnosis and Treatments", written by the: U.S. Department of Health and Human Services (Author), National Institute of Mental Health (Author), (Author), National Institutes of Health (Author) and S.Smith (Editor) and (Illustrator) This book has been professionally illustrated and edited with a fully hyper-linked table of contents for ease of navigation. A detailed booklet that describes Schizophrenia, symptoms, causes, and treatments, with information on getting help and coping. This booklet is also for family and friends that are looking for further understanding of schizophrenia. You will learn in this Booklet: What is schizophrenia? What are the symptoms of...
	Schizophrenia For Dummies by Jerome Levine (Author), Irene S. Levine (Author) Practical tools for leading a happy, productive life Schizophrenia is a chronic, severe, and disabling mental disorder that afflicts one percent of the population, an estimated 2.5 million people in America alone. The firsthand advice in this reassuring guide will empower the families and caregivers of schizophrenia patients to take charge, offering expert advice on identifying the warning signs, choosing the right health professional, understanding currently available drugs and those on the horizon (as well as their side effects), and evaluating traditional and alternative therapies.
	Schizophrenia Revealed: From Neurons to Social Interactions by Michael Foster Green (Author) For many years, schizophrenia was considered to be a deep and profound mystery. It was generally viewed as unknown and unknowable—beyond the reach of science.In the past ten years, major developments in scientific research have drastically changed the way schizophrenia is viewed. Neuroscience, in particular, has enabled researchers to frame different questions when investigating this illness and we are now coming to a deeper understanding of it. In this much-needed book, Michael Green, an expert in the neurocognition of schizophrenia, presents an integrated overview of schizophrenia covering a wide range of topics in lively, understandable prose. He outlines a neurodevelopmental model of schizophrenia, discusses neurocognitive indicators of genetic vulnerability, the...
	Schizophrenia by Daniel R. Weinberger (Editor), Paul Harrison (Editor) Schizophrenia is one of the most complex and disabling diseases to affect mankind.   Relatively little is known about its nature and its origins, and available treatments are inadequate for most patients. As a result, there are inevitable controversies about what causes it, how to diagnose it, and how best to treat it.   However, in the past decade, there has been an explosion of new research, with dramatic discoveries involving genetic etiology and epidemiological risk factors.  There has also been a catalog of new drugs coming to market, and controversy about the relative advantages and disadvantages of newer compared with older therapies.   In addition, developing technologies in genomics, molecular biology and neuroimaging provide streams of new information.This book represents a...
	Cognitive Therapy of Schizophrenia (Guides to Individualized Evidence-Based Treatment) by David G. Kingdon MD (Author), Douglas Turkington MD (Author) Drawing on the authors' decades of influential work in the field, this highly practical volume presents an evidence-based cognitive therapy approach for clients with schizophrenia. Guidelines are provided for collaborative assessment and case formulation that enable the clinician to build a strong therapeutic relationship, establish reasonable goals, and tailor treatment to each client's needs. Described in thorough, step-by-step detail are effective techniques for working with delusional beliefs, voices, visions, thought disorders, and negative symptoms; integrating cognitive therapy with other forms of treatment; reducing relapse risks; and enhancing client motivation. Special features include reproducible client handouts and assessment...